What are you looking for?

Atopic Dermatitis in Clinical Trials

Join our webinar to gain insight into the development and clinical testing of products to cure atopic dermatitis.


Atopic dermatitis is a chronic, inflammatory skin disease. The main symptom is pruritus (itching). Considered one of the most common skin diseases, it affects up to 10% of adults and 20% of children.

Although atopic dermatitis is not considered curable, patients can control the disease and alleviate symptoms using a variety of cosmetic and medical preparations. Therapeutic approaches often focus on skincare, itch relief, and anti-inflammatory and microbiome-restoring products.

This webinar will shed light on the clinical testing of products used to treat atopic dermatitis, based on these therapeutic approaches.


This webinar offers comprehensive insight into the development and clinical testing of products to treat atopic dermatitis.


  • Introduction
  • Background on atopic dermatitis
  • Scoring and evaluation in clinical trials
  • Patient-related outcomes and quality of life
  • Measurement methods
  • Q&A

Speaker: Dr Gunja Springmann, Head of Scientific Consulting at SGS proderm

Target Audience: The webinar is aimed at all manufacturers of products aimed at treating atopic dermatitis.

Language: English

Cost: No charge

For further information, please contact:

Sascha Faust
Marketing Manager
t: +49 40 839 358 34


Gunja Springmann

Head of Scientific Consulting, SGS proderm

Dr. Gunja Springmann

Related Webinars

News & Insights

  • SGS Headquarters

1 Place des Alpes,

P.O. Box 2152, 1211,

Geneva, Switzerland